temozolomide
Showing 51 - 75 of 556
Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)
Recruiting
- Neuroblastoma
- Naxitamab monotherapy
- +6 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 31, 2023
Metastatic Pancreatic Neuroendocrine Tumor, Unresectable Pancreatic Neuroendocrine Carcinoma Trial (Lutetium Lu 177 Dotatate,
Not yet recruiting
- Metastatic Pancreatic Neuroendocrine Tumor
- Unresectable Pancreatic Neuroendocrine Carcinoma
- Lutetium Lu 177 Dotatate
- +4 more
- (no location specified)
Feb 10, 2022
Extensive Stage Lung Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Recurrent Lung Small Cell Carcinoma Trial in
Recruiting
- Extensive Stage Lung Small Cell Carcinoma
- +5 more
- Atezolizumab
- Temozolomide
-
Indianapolis, Indiana
- +2 more
Oct 26, 2022
Malignant Tumor, Malignant Tumor of Brain Trial in Taiwan (NBM-BMX Capsule, Temozolomide, Standard radiotherapy)
Recruiting
- Malignant Neoplasm
- Malignant Neoplasm of Brain
- NBM-BMX Capsule
- +2 more
-
Hualien City, Taiwan
- +4 more
Aug 22, 2023
Primary CNS Lymphoma, PCNSL, Non Hodgkin Lymphoma Trial in Guandong, Guangzhou (Methotrexate, Ibrutinib, Temozolomide)
Recruiting
- Primary Central Nervous System Lymphoma
- +2 more
- Methotrexate
- +2 more
-
Guandong, Guangdong, China
- +2 more
Apr 6, 2022
Metastatic Colorectal Cancer Trial in Milan (Bevacizumab, Irinotecan, Leucovorin)
Recruiting
- Metastatic Colorectal Cancer
- Bevacizumab
- +4 more
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Apr 1, 2022
Glioblastoma Multiforme of Brain Trial (biological, procedure, radiation, drug)
Not yet recruiting
- Glioblastoma Multiforme of Brain
- TVI-Brain-1
- +3 more
- (no location specified)
Jan 13, 2023
Glioblastoma Trial in Ann Arbor (Dose-Intensified Radiotherapy, Temozolomide, Adjuvant temozolomide)
Recruiting
- Glioblastoma
- Dose-Intensified Radiotherapy
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Dec 16, 2021
Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York
Not yet recruiting
- Locally Advanced Leiomyosarcoma
- +8 more
- Olaparib
- +3 more
- (no location specified)
Jul 6, 2022
Small Cell Lung Cancer Trial in Boston (Olaparib, Temozolomide)
Active, not recruiting
- Small Cell Lung Cancer
- Olaparib
- Temozolomide
-
Boston, Massachusetts
- +2 more
Jan 24, 2022
Glioblastoma Multiforme Trial in Washington, Baltimore (Temozolomide)
Completed
- Glioblastoma Multiforme
- Temozolomide
-
Washington, District of Columbia
- +2 more
Nov 17, 2021
Glioblastoma Multiforme Trial in Cleveland (biological, drug, other, procedure, radiation)
Active, not recruiting
- Glioblastoma Multiforme
- MGMTP140K-encoding retroviral vector
- +6 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
May 6, 2022
Adenocarcinoma - GEJ, Cancer of Esophagus Trial in Cambridge (Temozolomide, Temozolomide 50mg/m2/day, Temozolomide 3 month)
Recruiting
- Adenocarcinoma - GEJ
- Cancer of Esophagus
- Temozolomide
- +3 more
-
Cambridge, Cambridgeshire, United KingdomCambridge University Hospitals NHS Foundation Trust
Oct 6, 2021
Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,
Not yet recruiting
- Glioblastoma Multiforme
- +3 more
- P140K-MGMT
- +5 more
-
Bethesda, Maryland
- +1 more
Jul 4, 2022
Metastatic Colorectal Cancer Trial in Milan (Temozolomide, Nivolumab, Ipilimumab)
Completed
- Metastatic Colorectal Cancer
- Temozolomide
- +2 more
-
Milan, MI, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Apr 1, 2022
Glioblastoma Trial in Louisville (Hypofractionated radiotherapy, Temozolomide)
Recruiting
- Glioblastoma
- Hypofractionated radiotherapy
- Temozolomide
-
Louisville, KentuckyJames Graham Brown Cancer Center
Oct 22, 2021
Melanoma Trial in Shanghai (SHR-1701, Temozolomide)
Not yet recruiting
- Melanoma
- SHR-1701
- Temozolomide
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 1, 2021
Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma Trial in Los Angeles, San Diego (biological, drug, other, genetic)
Active, not recruiting
- Giant Cell Glioblastoma
- +2 more
- bevacizumab
- +5 more
-
Los Angeles, California
- +2 more
Feb 10, 2022
Glioblastoma Trial in Boston (Temozolomide, Bavituximab, Radiation)
Active, not recruiting
- Glioblastoma
- Temozolomide
- +2 more
-
Boston, Massachusetts
- +1 more
Oct 27, 2021